BioXcel Therapeutics, Inc. Common Stock (BTAI) is a publicly traded Healthcare sector company. As of September 23, 2026, BTAI trades at $0.07 with a market cap of $2.31M and a P/E ratio of -0.03. BTAI moved -37.19% today. Year to date, BTAI is -96.05%; over the trailing twelve months it is -98.05%. Its 52-week range spans $0.07 to $8.08. Rallies surfaces BTAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BTAI, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.07 |
| Market Cap | $2.31M |
| P/E Ratio | -0.03 |
| EPS | $-2.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.08 |
| 52-Week Low | $0.07 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $742.00K |
| Net Income | $-70.86M |
| Gross Margin | 53.10% |
BTAI analyst coverage data. Average price target: $0.00.